Research ArticleAdult-Onset Still Disease/Systemic Juvenile Idiopathic Arthritis
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry
Piero Ruscitti, Ilenia Di Cola, Antonio Vitale, Valeria Caggiano, Pierpaolo Palumbo, Ernesto Di Cesare, Jiram Torres-Ruiz, Guillermo Arturo Guaracha-Basañez, Eduardo Martín-Nares, Francesco Ciccia, Daniela Iacono, Flavia Riccio, Maria Cristina Maggio, Samar Tharwat, Soad Hashad, Donato Rigante, Augusta Ortolan, Henrique A. Mayrink Giardini, Isabele Parente de Brito Antonelli, Rafael Alves Cordeiro, Roberto Giacomelli, Luca Navarini, Onorina Berardicurti, Alessandro Conforti, Daniela Opris-Belinski, Jurgen Sota, Carla Gaggiano, Giuseppe Lopalco, Fiorenzo Iannone, Francesco La Torre, Violetta Mastrorilli, Marcello Govoni, Francesca Ruffilli, Giacomo Emmi, Edoardo Biancalana, Petros P. Sfikakis, Maria Tektonidou, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Özgül Soysal Gündüz, Giovanni Conti, Serena Patroniti, Antonio Gidaro, Arianna Bartoli, Alma Nunzia Olivieri, M. Francesca Gicchino, Antonio Luca Brucato, Lorenzo Dagna, Alessandro Tomelleri, Corrado Campochiaro, Amato De Paulis, Ilaria Mormile, Francesca Della Casa, Haner Direskeneli, Fatma Alibaz-Oner, Anastasios Karamanakos, Aikaterini Dimouli, Gaafar Ragab, Ayman Abdelmonem Ahmed Mahmoud, Abdurrahman Tufan, Hamit Kucuk, Riza Kardas, Ezgi D. Batu, Seza Ozen, Ewa Wiesik-Szewczyk, Andrea Hinojosa-Azaola, Alberto Balistreri, Claudia Fabiani, Bruno Frediani and Luca Cantarini on behalf of the International AIDA Network and the Autoinflammatory Diseases Working Group of the Italian Society of Rheumatology
The Journal of Rheumatology March 2025, 52 (3) 226-233; DOI: https://doi.org/10.3899/jrheum.2024-0683
Piero Ruscitti
1P. Ruscitti, MD, PhD, I. Di Cola, MD, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;
Ilenia Di Cola
1P. Ruscitti, MD, PhD, I. Di Cola, MD, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;
Antonio Vitale
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Valeria Caggiano
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Pierpaolo Palumbo
3P. Palumbo, MD, E. Di Cesare, MD, Department of Diagnostic Imaging, Area of Cardiovascular and Interventional Imaging, Abruzzo Health Unit 1, L’Aquila, Italy;
Ernesto Di Cesare
3P. Palumbo, MD, E. Di Cesare, MD, Department of Diagnostic Imaging, Area of Cardiovascular and Interventional Imaging, Abruzzo Health Unit 1, L’Aquila, Italy;
Jiram Torres-Ruiz
4J. Torres-Ruiz, MD, G.A. Guaracha-Basañez, MD, E. Martín-Nares, MD, A. Hinojosa-Azaola, MD, Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico;
Guillermo Arturo Guaracha-Basañez
4J. Torres-Ruiz, MD, G.A. Guaracha-Basañez, MD, E. Martín-Nares, MD, A. Hinojosa-Azaola, MD, Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico;
Eduardo Martín-Nares
4J. Torres-Ruiz, MD, G.A. Guaracha-Basañez, MD, E. Martín-Nares, MD, A. Hinojosa-Azaola, MD, Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico;
Francesco Ciccia
5F. Ciccia, MD, D. Iacono, MD, F. Riccio, MD, Department of Precision Medicine, University of Campania “Luigi Vanvitelli,” Naples, Italy;
Daniela Iacono
5F. Ciccia, MD, D. Iacono, MD, F. Riccio, MD, Department of Precision Medicine, University of Campania “Luigi Vanvitelli,” Naples, Italy;
Flavia Riccio
5F. Ciccia, MD, D. Iacono, MD, F. Riccio, MD, Department of Precision Medicine, University of Campania “Luigi Vanvitelli,” Naples, Italy;
Maria Cristina Maggio
6M.C. Maggio, MD, University Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro,” University of Palermo, Palermo, Italy;
Samar Tharwat
7S. Tharwat, MD, Rheumatology and Immunology Unit, Internal Medicine Department, Mansoura University, Mansoura, and Department of Internal Medicine, Faculty of Medicine, Horus University, New Damietta, Egypt;
Soad Hashad
8S. Hashad, MD, Rheumatology Department, Tripoli Children Hospital, Tripoli, Libya;
Donato Rigante
9D. Rigante, MD, Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, and Università Cattolica Sacro Cuore, Rome, Italy;
Augusta Ortolan
10A. Ortolan, MD, Rheumatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
Henrique A. Mayrink Giardini
11H.A. Mayrink Giardini, MD, I.P. de Brito Antonelli, MD, R.A. Cordeiro, MD, Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil;
Isabele Parente de Brito Antonelli
11H.A. Mayrink Giardini, MD, I.P. de Brito Antonelli, MD, R.A. Cordeiro, MD, Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil;
Rafael Alves Cordeiro
11H.A. Mayrink Giardini, MD, I.P. de Brito Antonelli, MD, R.A. Cordeiro, MD, Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil;
Roberto Giacomelli
12R. Giacomelli, MD, L. Navarini, MD, O. Berardicurti, MD, Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, and Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome “Campus Biomedico” School of Medicine, Rome, Italy;
Luca Navarini
12R. Giacomelli, MD, L. Navarini, MD, O. Berardicurti, MD, Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, and Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome “Campus Biomedico” School of Medicine, Rome, Italy;
Onorina Berardicurti
12R. Giacomelli, MD, L. Navarini, MD, O. Berardicurti, MD, Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, and Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome “Campus Biomedico” School of Medicine, Rome, Italy;
Alessandro Conforti
13A. Conforti, MD, U.O. Medicina Generale, Ospedale San Paolo di Civitavecchia, ASL Roma 4, Civitavecchia, Rome, Italy;
Daniela Opris-Belinski
14D. Opris-Belinski, MD, Rheumatology and Internal Medicine Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Jurgen Sota
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Carla Gaggiano
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Giuseppe Lopalco
15G. Lopalco, MD, F. Iannone, MD, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy;
Fiorenzo Iannone
15G. Lopalco, MD, F. Iannone, MD, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy;
Francesco La Torre
16F. La Torre, MD, V. Mastrorilli, MD, Department of Pediatrics, Pediatric Rheumatology Center, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy;
Violetta Mastrorilli
16F. La Torre, MD, V. Mastrorilli, MD, Department of Pediatrics, Pediatric Rheumatology Center, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy;
Marcello Govoni
17M. Govoni, MD, F. Ruffilli, MD, Rheumatology Unit, Department of Medical Sciences, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Ferrara, Italy;
Francesca Ruffilli
17M. Govoni, MD, F. Ruffilli, MD, Rheumatology Unit, Department of Medical Sciences, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Ferrara, Italy;
Giacomo Emmi
18G. Emmi, MD, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, and Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy, and Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Melbourne, Australia;
Edoardo Biancalana
19E. Biancalana, MD, Department of Experimental and Clinical Medicine, Florence, Italy;
Petros P. Sfikakis
20P.P. Sfikakis, MD, M. Tektonidou, MD, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece;
Maria Tektonidou
20P.P. Sfikakis, MD, M. Tektonidou, MD, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece;
José Hernández-Rodríguez
21J. Hernández-Rodríguez, MD, V. Gómez-Caverzaschi, MD, Department of Autoimmune Diseases, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic of Barcelona (ERN-RITA Center), University of Barcelona, Barcelona, Spain;
Verónica Gómez-Caverzaschi
21J. Hernández-Rodríguez, MD, V. Gómez-Caverzaschi, MD, Department of Autoimmune Diseases, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic of Barcelona (ERN-RITA Center), University of Barcelona, Barcelona, Spain;
Özgül Soysal Gündüz
22Ö.S. Gündüz, MD, Department of Internal Medicine, Division of Rheumatology, Celal Bayar University School of Medicine, Manisa, Turkey;
Giovanni Conti
23G. Conti, MD, S. Patroniti, MD, Pediatric Nephrology and Rheumatology Unit, Azienda Ospedaliera Universitaria (AOU), “G. Martino” Messina, Italy;
Serena Patroniti
23G. Conti, MD, S. Patroniti, MD, Pediatric Nephrology and Rheumatology Unit, Azienda Ospedaliera Universitaria (AOU), “G. Martino” Messina, Italy;
Antonio Gidaro
24A. Gidaro, MD, A. Bartoli, MD, Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy;
Arianna Bartoli
24A. Gidaro, MD, A. Bartoli, MD, Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy;
Alma Nunzia Olivieri
25A.N. Olivieri, MD, M.F. Gicchino, MD, Department of Woman, Child and of General and Specialized Surgery, University of Campania “Luigi Vanvitelli,” Naples, Italy;
M. Francesca Gicchino
25A.N. Olivieri, MD, M.F. Gicchino, MD, Department of Woman, Child and of General and Specialized Surgery, University of Campania “Luigi Vanvitelli,” Naples, Italy;
Antonio Luca Brucato
26A.L. Brucato, MD, Pediatric Unit, Fatebenefratelli Hospital, Milan, Italy;
Lorenzo Dagna
27L. Dagna, MD, A. Tomelleri, MD, C. Campochiaro, MD, School of Medicine, Vita-Salute San Raffaele University, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy;
Alessandro Tomelleri
27L. Dagna, MD, A. Tomelleri, MD, C. Campochiaro, MD, School of Medicine, Vita-Salute San Raffaele University, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy;
Corrado Campochiaro
27L. Dagna, MD, A. Tomelleri, MD, C. Campochiaro, MD, School of Medicine, Vita-Salute San Raffaele University, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy;
Amato De Paulis
28A. De Paulis, MD, Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Naples, Italy;
Ilaria Mormile
29I. Mormile, MD, F. Della Casa, MD, Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy;
Francesca Della Casa
29I. Mormile, MD, F. Della Casa, MD, Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy;
Haner Direskeneli
30H. Direskeneli, MD, F. Alibaz-Oner, MD, Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey;
Fatma Alibaz-Oner
30H. Direskeneli, MD, F. Alibaz-Oner, MD, Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey;
Anastasios Karamanakos
31A. Karamanakos, MD, A. Dimouli, MD, Department of Rheumatology, “Evangelismos” General Hospital, Athens, Greece;
Aikaterini Dimouli
31A. Karamanakos, MD, A. Dimouli, MD, Department of Rheumatology, “Evangelismos” General Hospital, Athens, Greece;
Gaafar Ragab
32G. Ragab, MD, Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University, Giza, and Faculty of Medicine, Newgiza University, 6th of October City, Egypt;
Ayman Abdelmonem Ahmed Mahmoud
33A.A.A. Mahmoud, MD, Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt;
Abdurrahman Tufan
34A. Tufan, MD, H. Kucuk, MD, R. Kardas, MD, Gazi University Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey;
Hamit Kucuk
34A. Tufan, MD, H. Kucuk, MD, R. Kardas, MD, Gazi University Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey;
Riza Kardas
34A. Tufan, MD, H. Kucuk, MD, R. Kardas, MD, Gazi University Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey;
Ezgi D. Batu
35E.D. Batu, MD, S. Ozen, MD, Department of Pediatric Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey;
Seza Ozen
35E.D. Batu, MD, S. Ozen, MD, Department of Pediatric Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey;
Ewa Wiesik-Szewczyk
36E. Wiesik-Szewczyk, MD, Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, National Research Institute, Warsaw, Poland;
Andrea Hinojosa-Azaola
4J. Torres-Ruiz, MD, G.A. Guaracha-Basañez, MD, E. Martín-Nares, MD, A. Hinojosa-Azaola, MD, Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico;
Alberto Balistreri
37A. Balistreri, MD, Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena, and Azienda Ospedaliero-Universitaria Senese (ERN-RITA Center), Siena, Italy;
Claudia Fabiani
38C. Fabiani, MD, Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, and Azienda Ospedaliero-Universitaria Senese (ERN-RITA Center), Siena, Italy.
Bruno Frediani
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Luca Cantarini
2A. Vitale, MD, V. Caggiano, MD, J. Sota, MD, C. Gaggiano, MD, B. Frediani, MD, L. Cantarini, MD, PhD, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, University of Siena, and Azienda Ospedaliero-Universitaria Senese (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases [ERN-RITA] Center), Siena, Italy;
Abstract
Objective We aimed to (1) evaluate the cardiac involvement, with a focus on myocarditis, in patients with Still disease included in the multicenter Autoinflammatory Disease Alliance (AIDA) Network Still disease registry; and (2) assess the predictive factors for myocarditis by deriving a clinical risk patient profile for this severe manifestation.
Methods A multicenter observational study was established, in which consecutive patients with Still disease in the AIDA Network Still disease registry were characterized by cardiac involvement. Cardiac involvement was defined according to the presence of pericarditis, tamponade, myocarditis, and/or aseptic endocarditis.
Results In total, 73 patients with Still disease and cardiac involvement were assessed (mean age 36.3 [SD 19.9] years; male sex, 42.5%), out of which 21.9% were children. The most common cardiac manifestation was pericarditis, occurring in 90.4% of patients; patients also presented with myocarditis (26%), and less frequently endocarditis (2.7%) and tamponade (1.4%). In comparing clinical features of patients with myocarditis to those without, significantly increased frequencies of skin rash and pleuritis, as well as higher systemic scores, were seen. Further, a higher mortality rate was shown in patients with myocarditis. In regression models, skin rash and the systemic score independently predicted the myocarditis.
Conclusion The characteristics of patients with Still disease and cardiac involvement were assessed in the AIDA Network. The most common feature was the pericarditis, but a more severe clinical picture was also reported in patients with myocarditis. The latter was associated with increased mortality rate and higher systemic score, identifying patients who should be carefully managed.
- Accepted for publication October 7, 2024.
- Copyright © 2025 by the Journal of Rheumatology
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
The Journal of Rheumatology
Vol. 52, Issue 3
1 Mar 2025
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry
Piero Ruscitti, Ilenia Di Cola, Antonio Vitale, Valeria Caggiano, Pierpaolo Palumbo, Ernesto Di Cesare, Jiram Torres-Ruiz, Guillermo Arturo Guaracha-Basañez, Eduardo Martín-Nares, Francesco Ciccia, Daniela Iacono, Flavia Riccio, Maria Cristina Maggio, Samar Tharwat, Soad Hashad, Donato Rigante, Augusta Ortolan, Henrique A. Mayrink Giardini, Isabele Parente de Brito Antonelli, Rafael Alves Cordeiro, Roberto Giacomelli, Luca Navarini, Onorina Berardicurti, Alessandro Conforti, Daniela Opris-Belinski, Jurgen Sota, Carla Gaggiano, Giuseppe Lopalco, Fiorenzo Iannone, Francesco La Torre, Violetta Mastrorilli, Marcello Govoni, Francesca Ruffilli, Giacomo Emmi, Edoardo Biancalana, Petros P. Sfikakis, Maria Tektonidou, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Özgül Soysal Gündüz, Giovanni Conti, Serena Patroniti, Antonio Gidaro, Arianna Bartoli, Alma Nunzia Olivieri, M. Francesca Gicchino, Antonio Luca Brucato, Lorenzo Dagna, Alessandro Tomelleri, Corrado Campochiaro, Amato De Paulis, Ilaria Mormile, Francesca Della Casa, Haner Direskeneli, Fatma Alibaz-Oner, Anastasios Karamanakos, Aikaterini Dimouli, Gaafar Ragab, Ayman Abdelmonem Ahmed Mahmoud, Abdurrahman Tufan, Hamit Kucuk, Riza Kardas, Ezgi D. Batu, Seza Ozen, Ewa Wiesik-Szewczyk, Andrea Hinojosa-Azaola, Alberto Balistreri, Claudia Fabiani, Bruno Frediani, Luca Cantarini
The Journal of Rheumatology Mar 2025, 52 (3) 226-233; DOI: 10.3899/jrheum.2024-0683
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry
Piero Ruscitti, Ilenia Di Cola, Antonio Vitale, Valeria Caggiano, Pierpaolo Palumbo, Ernesto Di Cesare, Jiram Torres-Ruiz, Guillermo Arturo Guaracha-Basañez, Eduardo Martín-Nares, Francesco Ciccia, Daniela Iacono, Flavia Riccio, Maria Cristina Maggio, Samar Tharwat, Soad Hashad, Donato Rigante, Augusta Ortolan, Henrique A. Mayrink Giardini, Isabele Parente de Brito Antonelli, Rafael Alves Cordeiro, Roberto Giacomelli, Luca Navarini, Onorina Berardicurti, Alessandro Conforti, Daniela Opris-Belinski, Jurgen Sota, Carla Gaggiano, Giuseppe Lopalco, Fiorenzo Iannone, Francesco La Torre, Violetta Mastrorilli, Marcello Govoni, Francesca Ruffilli, Giacomo Emmi, Edoardo Biancalana, Petros P. Sfikakis, Maria Tektonidou, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Özgül Soysal Gündüz, Giovanni Conti, Serena Patroniti, Antonio Gidaro, Arianna Bartoli, Alma Nunzia Olivieri, M. Francesca Gicchino, Antonio Luca Brucato, Lorenzo Dagna, Alessandro Tomelleri, Corrado Campochiaro, Amato De Paulis, Ilaria Mormile, Francesca Della Casa, Haner Direskeneli, Fatma Alibaz-Oner, Anastasios Karamanakos, Aikaterini Dimouli, Gaafar Ragab, Ayman Abdelmonem Ahmed Mahmoud, Abdurrahman Tufan, Hamit Kucuk, Riza Kardas, Ezgi D. Batu, Seza Ozen, Ewa Wiesik-Szewczyk, Andrea Hinojosa-Azaola, Alberto Balistreri, Claudia Fabiani, Bruno Frediani, Luca Cantarini
The Journal of Rheumatology Mar 2025, 52 (3) 226-233; DOI: 10.3899/jrheum.2024-0683
